ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,81
-0,25%
Dow Jones
39 898,27
0,07%
DAX
18 711,20
-0,08%
Brent Oil
83,385
0,22%
Bitcoin
66 967,96
2,65%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Adma Biologics Inc (ADMA)

  7. Adma Biologics Inc (ADMA) Actualités

ADMA

Adma Biologics (ADMA)

Adma Biologics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ADMA
DateHeureSourceTitreSymboleSociété
17/05/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
09/05/202423h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADMAAdma Biologics Inc
09/05/202422h05GlobeNewswire Inc.ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
09/05/202413h47IH Market NewsU.S. Index Futures Dip, Bank of England Holds Interest Rates at 5.25%NASDAQ:ADMAAdma Biologics Inc
02/05/202413h00GlobeNewswire Inc.ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:ADMAAdma Biologics Inc
11/03/202417h19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADMAAdma Biologics Inc
11/03/202412h00GlobeNewswire Inc.ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®NASDAQ:ADMAAdma Biologics Inc
09/03/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
05/03/202413h00GlobeNewswire Inc.ADMA Biologics to Participate in the Raymond James Institutional Investor ConferenceNASDAQ:ADMAAdma Biologics Inc
28/02/202422h10GlobeNewswire Inc.ADMA Biologics Announces CFO TransitionNASDAQ:ADMAAdma Biologics Inc
28/02/202422h05GlobeNewswire Inc.ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
21/02/202422h05GlobeNewswire Inc.ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:ADMAAdma Biologics Inc
21/02/202413h00GlobeNewswire Inc.ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlyticsNASDAQ:ADMAAdma Biologics Inc
14/02/202417h50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADMAAdma Biologics Inc
08/01/202413h00GlobeNewswire Inc.ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
18/12/202322h05GlobeNewswire Inc.ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares ManagementNASDAQ:ADMAAdma Biologics Inc
12/12/202313h00GlobeNewswire Inc.ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and OlderNASDAQ:ADMAAdma Biologics Inc
16/11/202313h00GlobeNewswire Inc.ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MDNASDAQ:ADMAAdma Biologics Inc
08/11/202322h05GlobeNewswire Inc.ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
01/11/202312h00GlobeNewswire Inc.ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023NASDAQ:ADMAAdma Biologics Inc
02/10/202322h46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
22/08/202323h09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ADMAAdma Biologics Inc
18/08/202318h58Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:ADMAAdma Biologics Inc
09/08/202322h05GlobeNewswire Inc.ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
02/08/202313h00GlobeNewswire Inc.ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023NASDAQ:ADMAAdma Biologics Inc
06/06/202322h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMAAdma Biologics Inc
22/05/202313h32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMAAdma Biologics Inc
10/05/202323h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMAAdma Biologics Inc
10/05/202322h05GlobeNewswire Inc.ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
03/05/202313h00GlobeNewswire Inc.ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023NASDAQ:ADMAAdma Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:ADMA

Dernières Valeurs Consultées

EU
IDECR
AMUNDI DECR INAV
LSE
SNG
Synairgen
NASDAQ
FATE
Fate Therapeutics
NASDAQ
GLACW
Greenland Acquisition
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés